Watch Highlights from sessions at the 2021 Virtual CJD Foundation Family Conference:
What do we have to be optimistic about?
Hear from Brian Appleby, MD, Medical Director, CJD Foundation, and Director, NPDPSC; Inga Zerr, MD, German Center for Neurodegenerative Diseases – National Reference Ctr. for Surveillance of Transmissible Spongiform Encephalopathies, Germany; Alberto Bizzi, MD, Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy; and Simon Mead, PhD, University College London (UCL) Institute of Prion Diseases discuss this during a research grant recipients panel discussion.
Watch Presentation
What do we think might cause Sporadic CJD?
Hear from Dr. Pierluigi Gambetti, Founder and Retired Director, National Prion Disease Pathology Surveillance Center (NPDPSC) and Brian Appleby, MD, Medical Director, CJD Foundation, and Director, NPDPSC discuss this during the keynote session.
Watch Presentation
What is the utility of biomarkers in interpreting whether [a potential future] treatment is working in Prion Disease?
Hear from Brian Appleby, MD, Medical Director, CJD Foundation, and Director, NPDPSC; Inga Zerr, MD, German Center for Neurodegenerative Diseases – National Reference Ctr. for Surveillance of Transmissible Spongiform Encephalopathies, Germany; Alberto Bizzi, MD, Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy; and Simon Mead, PhD, University College London (UCL) Institute of Prion Diseases discuss this during a research grant recipients panel discussion.
Watch Presentation
Is there any relation between the COVID-19 vaccine and CJD?
Hear from Ryan Maddox, PhD, Epidemiologist, Prion and Public Health Office Division of High-Consequence Pathogens and Pathology, CDC who discusses this during the 2021 Centers for Disease Control and Prevention (CDC) Report session.
Watch Presentation
What is a phenotype, and what does it mean? For example, what does MM1 or VV2 mean?
Hear from Brian Appleby, MD, Medical Director, CJD Foundation, and Director, NPDPSC who discusses Prion Disease Phenotypes during the keynote session.
Watch Presentation